Mangoceuticals (NASDAQ: MGRX) — Perfil da empresa, notícias e dados financeiros
Mangoceuticals is focused on developing innovative pharmaceutical and healthcare products that address unmet medical needs.
Mangoceuticals
Mangoceuticals (NASDAQ:MGRX) focuses on the development and commercialization of innovative pharmaceutical and healthcare products. With a diverse portfolio that spans from groundbreaking therapies to wellness products, Mangoceuticals aims to improve the quality of life by addressing unmet medical needs. Its projects range from early-stage drug discovery to advanced clinical trials, targeting a variety of therapeutic areas. Besides its primary listing, Mangoceuticals is committed to expanding its impact, striving to become a household name in health and wellness solutions while maintaining a strong ethical framework and sustainability in its operations.
Resumo
Operações
Produtos e/ou serviços de Mangoceuticals
- Development of innovative oncology treatments targeting rare and difficult to treat cancers.
- Research and production of advanced skincare products incorporating novel biotech ingredients.
- Partnership initiatives for global distribution of its patented pharmaceutical products.
- Creation of a state-of-the-art biotechnology research facility focused on genetic and cell therapy.
- Investment in AI-driven drug discovery platforms to accelerate the development of new medications.
- Launching a telemedicine service offering personalized healthcare consultations and prescription services.
equipe executiva do Mangoceuticals
- Jacob D. CohenCo-Founder, CEO & Chairman
- Eugene M. JohnstonChief Financial Officer
Principais indicadores financeiros
Resultados divulgados pela Mangoceuticals , em USD.
- Cap. de mercado
- 5,5 mi
- Receita (TTM)
- 315,2 mil
- P/L
- —
- LPA (diluído, TTM)
- -1.0
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 456 mil | -19,2 mi | -20,6 mi | |
| 615,9 mil | -8 mi | -8,7 mi | |
| 731,5 mil | -9,2 mi | -9,2 mi | |
| 8,9 mil | -2 mi | -2 mi |